David Rescott

Stock Analyst at Baird

(1.47)
# 1485
Out of 5,329 analysts
69
Total ratings
55.26%
Success rate
12.34%
Average return
10 Stocks
Name Action PT Current % Upside Ratings Updated
MMSI Merit Medical System...
Maintains: Outperform
111 110
93.28 17.92% 3 Apr 25, 2025
PEN Penumbra
Maintains: Strong Buy
315 330
291.69 13.13% 29 Apr 24, 2025
EW Edwards Lifesciences
Maintains: Neutral
72 75
75.33 -0.44% 4 Apr 24, 2025
BSX Boston Scientific
Maintains: Outperform
115 120
103.16 16.32% 5 Apr 24, 2025
ISRG Intuitive Surgical
Maintains: Outperform
600 575
517.45 11.12% 3 Apr 23, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
90 91
83.44 9.06% 4 Feb 19, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
81 80
n/a n/a 4 Jan 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
66 72
36.84 95.44% 3 Oct 31, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
73 71
n/a n/a 8 Jan 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
25 26
13.69 89.92% 6 Dec 22, 2023